Ethanol drinking and the basal ganglia circuitry

乙醇饮用和基底神经节回路

基本信息

  • 批准号:
    10513411
  • 负责人:
  • 金额:
    $ 33.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-15 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Alcohol use disorder (AUD) is characterized by inflexible compulsive drinking despite negative consequences. This behavioral inflexibility is associated with deficits in reversal learning. The thalamus and the dorsomedial striatum (DMS) are critical reversal learning in flexible behavior. The DMS contains principal medium spiny neurons (MSNs). MSNs are located either in the direct-pathway (dMSNs) or indirect-pathway (iMSNs) of the basal ganglia. Both dMSNs and iMSNs receive cortical inputs and positively and negatively regulate the selection of “Go” actions, respectively. The DMS also contains cholinergic interneurons (CINs). CIN release acetylcholine to modulate MSN activity. During reversal learning, thalamic inputs excite DMS CINs to generate burst-pause firing and stop ongoing actions. It is not known how thalamically evoked CIN activity regulates MSNs in AUD and contributes to inflexible behavior. The goal of this application is to study how excessive ethanol intake alters thalamostriatal transmission, leading to behavioral inflexibility. Our long-term objective is to develop new therapeutics to restore behavioral flexibility and treat AUD. The hypothesis, based in part on applicant’s preliminary results, is that excessive ethanol intake compromises thalamic regulation of DMS CINs and CIN-mediated regulation of cortical inputs onto dMSNs and iMSN, leading to inflexible behaviors, which can be counteracted by optogenetic excitation of thalamostriatal transmission onto CINs. We will test this hypothesis by pursuing the following three specific aims. (1) Investigate whether excessive ethanol intake reduces the burst-pause response of DMS CINs and acetylcholine release from CINs. (2) Determine whether excessive ethanol intake compromises CIN-mediated regulation of corticostriatal transmission in DMS MSNs. And (3) evaluate the ability of optogenetic excitation of thalamic inputs onto DMS CINs to improve reversal learning in animals with a history of excessive ethanol intake. This research is conceptually innovative because it focuses on the relatively neglected area of the cholinergic contribution to AUD. It is technically innovative in its use of combined genetically encoded acetylcholine sensors, dual-channel optogenetics, and rabies- mediated expression systems at a synapse with defined pre- and postsynaptic sites to determine the cholinergic contribution to ethanol-mediated inflexibility. These essential research questions cannot be addressed using conventional methodologies. Knowledge generated from this proposal will provide novel strategies for reversing inflexible behavior and thereby reduce excessive ethanol intake in AUD.
摘要 酒精使用障碍(AUD)的特点是尽管有负面后果,但仍顽固地强迫饮酒。 这种行为上的僵化与反转学习的缺陷有关。丘脑和背内侧 纹状体(DMS)是灵活行为中的关键反转学习。DMS含有主要的中刺 神经元(MSN)。MSN位于直接途径(DMSN)或间接途径(IMSN)中 基底节。DMSN和iMSN都接受皮质输入,并积极和消极地调节 分别选择“GO”动作。DMS还含有胆碱能中间神经元(CINs)。CIN释放 乙酰胆碱调节MSN活性。在反向学习过程中,丘脑的输入刺激DMS CIN产生 突发-暂停发射并停止正在进行的操作。目前尚不清楚丘脑诱发的CIN活性如何调节 AUD中的MSNS,并导致行为僵化。这个应用程序的目标是研究过度 酒精摄入改变了丘脑纹状体的传递,导致行为不灵活。我们的长期目标是 开发新的治疗方法以恢复行为灵活性和治疗AUD。这一假说,部分基于 申请人的初步结果是,过量的酒精摄入损害了丘脑对DMS CINs的调节 和CIN介导的皮质输入对dMSN和IMSN的调节,导致不灵活的行为,这 可被丘脑纹状体传递到CINs的光遗传兴奋所抵消。我们将对此进行测试 通过追求以下三个具体目标来实现假设。(1)调查过量饮酒是否 减少DMS CINs的突发-暂停反应和CINs释放的乙酰胆碱。(2)确定是否 过量的乙醇摄入损害了CIN介导的DMS MSN皮质纹状体传递的调节。 以及(3)评价丘脑对DMS CINs的光发生兴奋促进逆转的能力 有过量酒精摄取史的动物的学习。这项研究在概念上是创新的,因为 它集中在相对被忽视的胆碱能对AUD的贡献领域。它在技术上是创新的 它结合了基因编码的乙酰胆碱传感器、双通道光遗传学和狂犬病- 突触上具有确定的突触前和突触后位置的中介表达系统来确定 胆碱能在乙醇介导的僵硬中的作用。这些基本的研究问题不可能是 使用传统方法解决问题。从这项提案中产生的知识将提供新的 扭转僵化行为的策略,从而减少AUD的过量酒精摄入量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jun Wang其他文献

Spiking Neural Systems with Weights
带权重的尖峰神经系统
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Jun Wang;Hendrik Jan Hoogeboom;Gheorghe Paun;Linqiang Pan
  • 通讯作者:
    Linqiang Pan

Jun Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jun Wang', 18)}}的其他基金

Striatal ensemble plasticity in alcohol use disorder
酒精使用障碍中的纹状体整体可塑性
  • 批准号:
    10734890
  • 财政年份:
    2023
  • 资助金额:
    $ 33.37万
  • 项目类别:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
开发针对病毒主要蛋白酶和宿主组织蛋白酶 L 的双重抑制剂作为 SARS-CoV-2 抗病毒药物
  • 批准号:
    10457835
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
高分辨率空间 MIST 技术用于阿尔茨海默病神经炎症的功能蛋白质组学研究
  • 批准号:
    10343115
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Repurposing of Maraviroc for the treatment of neuropathic pain
重新利用马拉韦罗治疗神经性疼痛
  • 批准号:
    10586296
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
CCL5/CCR5轴在抑郁症中的性别特异性作用及其治疗意义
  • 批准号:
    10364861
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
NanoDiagnotic Technology I-Corps Training
纳米诊断技术 I-Corps 培训
  • 批准号:
    10541690
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
开发针对病毒主要蛋白酶和宿主组织蛋白酶 L 的双重抑制剂作为 SARS-CoV-2 抗病毒药物
  • 批准号:
    10543633
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
开发针对病毒主要蛋白酶和宿主组织蛋白酶 L 的双重抑制剂作为 SARS-CoV-2 抗病毒药物
  • 批准号:
    10693823
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
CCL5/CCR5轴在抑郁症中的性别特异性作用及其治疗意义
  • 批准号:
    10653682
  • 财政年份:
    2022
  • 资助金额:
    $ 33.37万
  • 项目类别:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
通过簇诱导穷举反应快速检测感染性病毒颗粒
  • 批准号:
    10443877
  • 财政年份:
    2021
  • 资助金额:
    $ 33.37万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.37万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了